Search research articles
Contact Us
Filters
Showing results (21-30 of 55) with videos related to
Page
of 6
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 1, 1986
Immunomodulating properties of bestatin in cancer patients. A phase II trial
G Mathé, H Umezawa, J L Misset, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 1, 1996
Single agent activity of oxaliplatin in heavily pretreated advanced epithelial ovarian cancer
P Chollet, M A Bensmaïne, S Brienza, et al.
American Journal of Clinical Oncology
|
June 17, 1998
Synergistic activity of oxaliplatin and 5-fluorouracil in patients with metastatic colorectal cancer with progressive disease while on or after 5-fluorouracil
F deBraud, E Munzone, F Nolè, et al.
Revue Medicale De Bruxelles
|
November 24, 2015
[Rehabilitation after total knee arthroplasty of hip and knee]
E Jansen, S Brienza, A Gierasimowicz-Fontana, et al.
Cancer Chemotherapy and Pharmacology
|
April 6, 2002
Influence of oxaliplatin on 5-fluorouracil plasma clearance and clinical consequences
M Boisdron-Celle, C Craipeau, S Brienza, et al.
Academic Medicine : Journal of the Association of American Medical Colleges
|
June 30, 2016
Modifying the Primary Care Exception Rule to Require Competency-Based Assessment
Daniel G Tobin, Benjamin R Doolittle, Matthew S Ellman, et al.
The Journal of Infusional Chemotherapy
|
January 1, 1995
Circadian rhythm-modulated (CRM) chemotherapy of metastatic breast cancer with mitoxantrone, 5-fluorouracil, and folinic acid: preliminary results of a phase I trial
P Deprés-Brummer, F Berthault-Cvitkovic, F Lĕvi, et al.
Anti-Cancer Drugs
|
June 23, 1998
Oxaliplatin combined to 5-fluorouracil and folinic acid: an effective therapy in patients with advanced colorectal cancer
B Gerard, H Bleiberg, D Van Daele, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 13, 2001
Single-agent oxaliplatin in pretreated advanced breast cancer patients: a phase II study
C Garufi, C Nisticò, S Brienza, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Circadian rhythm-modulated chemotherapy with high-dose 5-fluorouracil: a pilot study in patients with pancreatic adenocarcinoma
F Bertheault-Cvitkovic, F Lévi, S Soussan, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 55) with videos related to
Sort By:
Page
of 6
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 1, 1986
Immunomodulating properties of bestatin in cancer patients. A phase II trial
G Mathé, H Umezawa, J L Misset, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 1, 1996
Single agent activity of oxaliplatin in heavily pretreated advanced epithelial ovarian cancer
P Chollet, M A Bensmaïne, S Brienza, et al.
American Journal of Clinical Oncology
|
June 17, 1998
Synergistic activity of oxaliplatin and 5-fluorouracil in patients with metastatic colorectal cancer with progressive disease while on or after 5-fluorouracil
F deBraud, E Munzone, F Nolè, et al.
Revue Medicale De Bruxelles
|
November 24, 2015
[Rehabilitation after total knee arthroplasty of hip and knee]
E Jansen, S Brienza, A Gierasimowicz-Fontana, et al.
Cancer Chemotherapy and Pharmacology
|
April 6, 2002
Influence of oxaliplatin on 5-fluorouracil plasma clearance and clinical consequences
M Boisdron-Celle, C Craipeau, S Brienza, et al.
Academic Medicine : Journal of the Association of American Medical Colleges
|
June 30, 2016
Modifying the Primary Care Exception Rule to Require Competency-Based Assessment
Daniel G Tobin, Benjamin R Doolittle, Matthew S Ellman, et al.
The Journal of Infusional Chemotherapy
|
January 1, 1995
Circadian rhythm-modulated (CRM) chemotherapy of metastatic breast cancer with mitoxantrone, 5-fluorouracil, and folinic acid: preliminary results of a phase I trial
P Deprés-Brummer, F Berthault-Cvitkovic, F Lĕvi, et al.
Anti-Cancer Drugs
|
June 23, 1998
Oxaliplatin combined to 5-fluorouracil and folinic acid: an effective therapy in patients with advanced colorectal cancer
B Gerard, H Bleiberg, D Van Daele, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 13, 2001
Single-agent oxaliplatin in pretreated advanced breast cancer patients: a phase II study
C Garufi, C Nisticò, S Brienza, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Circadian rhythm-modulated chemotherapy with high-dose 5-fluorouracil: a pilot study in patients with pancreatic adenocarcinoma
F Bertheault-Cvitkovic, F Lévi, S Soussan, et al.
Page
of 6